Oncolytics Biotech (TSE:ONC) Shares Pass Below 200-Day Moving Average – Here’s Why

Oncolytics Biotech Inc. (TSE:ONC) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$1.39 and traded as low as C$1.18. Oncolytics Biotech shares last traded at C$1.21, with a volume of 144,265 shares trading hands.

Analysts Set New Price Targets

Separately, Raymond James upgraded shares of Oncolytics Biotech to a “moderate buy” rating in a report on Thursday, November 14th.

Oncolytics Biotech Stock Down 3.2 %

The stock has a market capitalization of C$93.00 million, a P/E ratio of -3.18 and a beta of 1.35. The stock has a 50 day moving average price of C$1.33 and a 200-day moving average price of C$1.39. The company has a debt-to-equity ratio of 6.09, a current ratio of 4.99 and a quick ratio of 8.86.

Oncolytics Biotech Company Profile

Oncolytics Biotech Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.